Molecular markers for gastric adenocarcinoma: an update (Q36677268)

15 August 2017

1 reference

title

Molecular markers for gastric adenocarcinoma: an update (English)

1 reference

15 August 2017

1 reference

gastric adenocarcinoma

1 reference

Casandra Anderson

1 reference

15 August 2017

Amar Nijagal

series ordinal

1 reference

15 August 2017

Joseph Kim

series ordinal

1 reference

15 August 2017

publication date

1 January 2006

1 reference

Molecular Diagnosis and Therapy

15 August 2017

published in

1 reference

15 August 2017

1 reference

15 August 2017

1 reference

15 August 2017

page(s)

345-352

1 reference

Cancer pharmacogenomics: international trends

15 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FBF03256211

Pharmacogenetics/genomics and personalized medicine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256211

Pharmacogenomics and stomach cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256211

rHuEPO and treatment outcomes: the clinical experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256211

Subtotal versus total gastrectomy for gastric cancer: five-year survival rates in a multicenter randomized Italian trial. Italian Gastrointestinal Tumor Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256211

Combined 5-fluorouracil and supervoltage radiation therapy of locally unresectable gastrointestinal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256211

Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256211

Adjuvant therapy after curative resection for gastric cancer: meta-analysis of randomized trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256211

Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256211

Report of two protocol planned interim analyses in a randomised multicentre phase III study comparing capecitabine with fluorouracil and oxaliplatin with cisplatin in patients with advanced oesophagogastric cancer receiving ECF.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256211

Randomized multicenter phase II trial of a biweekly regimen of fluorouracil and leucovorin (LV5FU2), LV5FU2 plus cisplatin, or LV5FU2 plus irinotecan in patients with previously untreated metastatic gastric cancer: a Federation Francophone de Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256211

Docetaxel in advanced gastric cancer--review of the main clinical trials.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256211

Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256211

Effect of the tyrosine kinase inhibitor STI571 in a patient with a metastatic gastrointestinal stromal tumor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256211

Trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256211

The effectiveness of trastuzumab (Herceptin) combined with chemotherapy for gastric carcinoma with overexpression of the c-erbB-2 protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256211

Prediction of sensitivity to fluoropyrimidines by metabolic and target enzyme activities in gastric cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256211

Thymidylate synthase mRNA level in adenocarcinoma of the stomach: a predictor for primary tumor response and overall survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256211

The expression of thymidine phosphorylase correlates with angiogenesis and the efficacy of chemotherapy using fluorouracil derivatives in advanced gastric carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256211

Combined GADD45A and thymidine phosphorylase expression levels predict response and survival of neoadjuvant-treated gastric cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256211

REG gene expression is associated with the infiltrating growth of gastric carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256211

Expression of polo-like kinase 1 (PLK1) protein predicts the survival of patients with gastric carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256211

Vascular endothelial growth factor-D and its receptor VEGFR-3: two novel independent prognostic markers in gastric adenocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256211

p53 and VEGF expression are independent predictors of tumour recurrence and survival following curative resection of gastric cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256211

Biological markers as a predictor for response and prognosis of unresectable gastric cancer patients treated with irinotecan and cisplatin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256211

p53 protein overexpression as a predictor of the response to chemotherapy in gastric cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256211

Chemotherapy and radiotherapy in the management of gastric cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256211

Thymidylate synthase pharmacogenetics

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256211

Establishment and characterization of 5-fluorouracil-resistant gastric cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256211

The modulated oral fluoropyrimidine prodrug S-1, and its use in gastrointestinal cancer and other solid tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256211

Metabolism of Cisplatin to a nephrotoxin in proximal tubule cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256211

Apoptosis - the p53 network

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256211

p53-dependent apoptosis modulates the cytotoxicity of anticancer agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256211

Expression of carbonic anhydrase IX (CA IX), a hypoxia-related protein, rather than vascular-endothelial growth factor (VEGF), a pro-angiogenic factor, correlates with an extremely poor prognosis in esophageal and gastric adenocarcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256211

Identification of genes differentially expressed between gastric cancers and normal gastric mucosa with cDNA microarrays

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256211

Possible chemoresistance-related genes for gastric cancer detected by cDNA microarray

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256211

Identification of genes with differential expression in acquired drug-resistant gastric cancer cells using high-density oligonucleotide microarrays

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256211

DNA microarray analysis of the correlation between gene expression patterns and acquired resistance to 5-FU/cisplatin in gastric cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03256211

p27 downregulation and metallothionein overexpression in gastric cancer patients are associated with a poor survival rate

21 January 2018

1 reference

12 December 2020

Pharmacogenetic profiling and clinical outcome of patients with advanced gastric cancer treated with palliative chemotherapy

1 reference

12 December 2020

Adjuvant therapy for gastric carcinoma patients in the past 15 years: a review of western and oriental trials

1 reference

12 December 2020

Postoperative morbidity and mortality after D1 and D2 resections for gastric cancer: preliminary results of the MRC randomised controlled surgical trial

1 reference

12 December 2020

c-erbB-2 is of independent prognostic relevance in gastric cancer and is associated with the expression of tumor-associated protease systems

1 reference

12 December 2020

Randomized clinical trial on the combination of preoperative irradiation and surgery in the treatment of adenocarcinoma of gastric cardia (AGC)--report on 370 patients

1 reference

12 December 2020

Clinical impact of thymidine phosphorylase expression in gastric cancer.

1 reference

12 December 2020

Correlation of thymidylate synthase, thymidine phosphorylase and dihydropyrimidine dehydrogenase with sensitivity of gastrointestinal cancer cells to 5-fluorouracil and 5-fluoro-2'-deoxyuridine

1 reference

12 December 2020

Polymorphic tandem repeats in the thymidylate synthase gene is associated with its protein expression in human gastrointestinal cancers

1 reference

12 December 2020

Expression of thymidylate synthase, thymidine phosphorylase, dihydropyrimidine dehydrogenase, E2F-1, Bak, Bcl-X, and Bcl-2, and clinical outcomes for gastric cancer patients treated with bolus 5-fluorouracil

1 reference

12 December 2020

Potential prognostic significance of p185(HER2) overexpression with loss of PTEN expression in gastric carcinomas.

1 reference

12 December 2020

The prognostic significance of amplification and overexpression of c-met and c-erb B-2 in human gastric carcinomas

1 reference

12 December 2020

Biological markers as a predictor for response and prognosis of unresectable gastric cancer patients treated with 5-fluorouracil and cis-platinum.

1 reference

12 December 2020

p53, bcl-2 and thymidine phosphorylase as predictive markers of chemotherapy in patients with advanced and recurrent gastric cancer.

1 reference

12 December 2020

The concept of locally advanced gastric cancer. Effect of treatment on outcome. The Gastrointestinal Tumor Study Group

1 reference

12 December 2020

Randomised comparison of morbidity after D1 and D2 dissection for gastric cancer in 996 Dutch patients

1 reference

12 December 2020

Gastric Cancer Clinical Practice Guidelines

1 reference

12 December 2020

Expression of Cdx2 and the phenotype of advanced gastric cancers: relationship with prognosis

1 reference

12 December 2020

The isoenzymes of glutathione transferase

1 reference

12 December 2020

Expression of p53 protein and resistance to preoperative chemotherapy in locally advanced gastric carcinoma.

1 reference

12 December 2020

Soluble E-cadherin is an independent pretherapeutic factor for long-term survival in gastric cancer

1 reference

12 December 2020

Adjuvant chemotherapy in gastric cancer. The Italian experience and review of the literature.

1 reference

12 December 2020

Identification and functional analysis of single nucleotide polymorphism in the tandem repeat sequence of thymidylate synthase gene

1 reference

12 December 2020

Thymidylate synthase gene and protein expression correlate and are associated with response to 5-fluorouracil in human colorectal and gastric tumors

1 reference

12 December 2020

Prognostic significance of combined expression of MUC1 and adhesion molecules in advanced gastric cancer

1 reference

12 December 2020

Orotate phosphoribosyltransferase levels measured by a newly established enzyme-linked immunosorbent assay in gastric carcinoma

1 reference

12 December 2020

A novel single nucleotide polymorphism within the 5' tandem repeat polymorphism of the thymidylate synthase gene abolishes USF-1 binding and alters transcriptional activity

1 reference

12 December 2020

Adjuvant chemotherapy in gastric cancer: a meta-analysis of randomized trials and a comparison with previous meta-analyses

1 reference

12 December 2020

Overexpression of erbB-2 protein in gastric adenocarcinoma--a potential role in therapeutic response to adjuvant 5-FU-doxorubicin regimen

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF03256211

1 reference

15 August 2017

1 reference